Daniel H. Silverman, M.D., Ph.D., is Head of the Neuronuclear Imaging Section of the Ahmanson Translational Imaging Division at UCLA Medical Center, on the Executive Committee of the UCLA Alzheimer’s Disease Research Center, and a Professor in the Department of Molecular and Medical Pharmacology, University of California, Los Angeles. He obtained his Ph.D. in Biological Chemistry at Harvard University, and postdoctoral research training in Biochemistry and Molecular Pharmacology at Harvard Medical School. He obtained his M.D. from The Ohio State University College of Medicine, subsequently completed post-M.D. training at UCLA, and then obtained certification from both the American Board of Internal Medicine and the American Board of Nuclear Medicine.
Desmond Smith’s first degree was in Physics from Oxford University, England. He went on to obtain a PhD from Cambridge University in Molecular Biology and a medical degree from Oxford University. After postgraduate medical training in the UK, Dr Smith went to Harvard University to do a postdoctoral fellowship in Drosophila genetics and another postdoc at Lawrence Berkeley National Laboratory in mouse genetics. Dr Smith is currently a Professor at the Department of Molecular and Medical Pharmacology at UCLA.